Adverse effects and drug interactions of herbal medicines
- 作者Nursen Basaran; A. Ahmet Basaran
- 卷第189卷
- 文件大小50.59KB
- 发表时间2009
- DOI10.1016/j.toxlet.2009.06.106
Development and specification of physiologically based pharmacokinetic models for use in risk assessmentRebecca A. Clewell; Harvey J. Clewell III · 2008
Dose-dependence of chemical carcinogenicity: Biological mechanisms for thresholds and implications for risk assessmentClewell, Rebecca A.; Thompson, Chad M.; Clewell, Harvey J. · Chemico-Biological Interactions · 2019
PLETHEM – An interactive open-source platform for bridging the source-to-outcome continuumPendse, Salil; Clewell, Rebecca; Efremenko, Alina; McMullen, Patrick; Yoon, Miyoung; Clewell, Harvey · Toxicology Letters · 2017
Assessing the relevance of in vitro measures of phthalate inhibition of steroidogenesis for in vivo responseRebecca A. Clewell; Jerry L. Campbell; Susan M. Ross; Kevin W. Gaido; Harvey J. Clewell III; Melvin E. Andersen · 2010
An overview of PFAA pharmacokineticsHarvey Clewell; Anne Loccisano; Melvin Andersen · 2012
PrefaceMattie, David R.; Dodd, Darol E.; Clewell, Harvey J. · Toxicology Letters · 1993
IntroductionMattie, David R.; Dodd, Darol E.; Clewell, Harvey J. · 1993
Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalateGentry, P. Robinan; Clewell, Harvey J.; Clewell, Rebecca; Campbell, Jerry; Van Landingham, Cynthia; Shipp, Annette M. · Critical Reviews in Toxicology · 2011